PDXen

PDXen is a South Korean startup focusing on developing omics-based patient management systems. The company specializes in genome analysis and biological characteristics of blood cancer cells, establishing a micro cancer metastatic prediction and anticancer screening system. Utilizing a machine-learning-based algorithm, they aim to predict patient progression and have developed a drug susceptibility analysis system for biological characterization of disease-related cells. Their services and products include Realtime Cell Tracking System, Monitoring System for Minimal Residual Disease, Patient Care Service based on PHR, Patient-derived Xenograft Model Service for Cancer Progression, and Genetic and Microbiome Screening Service. Founded in 2013, PDXen operates in the Biotechnology and Health Care industries from their headquarters in South Korea. While the startup's last investment details are not available at the moment, its innovative approach to cancer management and treatment presents potential opportunities for investors in the biotech and healthcare sectors.